Tanaka, Yoshiya
Yamanaka, Hisashi
Ishiguro, Naoki
Miyasaka, Nobuyuki
Kawana, Katsuyoshi
Hiramatsu, Katsutoshi
Takeuchi, Tsutomu
Clinical trials referenced in this document:
Documents that mention this clinical trial
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
https://doi.org/10.1136/rmdopen-2015-000189
Documents that mention this clinical trial
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
https://doi.org/10.1136/rmdopen-2015-000189